Regencell Bioscience Holdings Ltd (NASDAQ:RGC) does about 2.93M shares in volume on a normal day but saw 18787612 shares change hands in the recent trading day. The company now has a market cap of 11.37B USD. Its current market price is $22.99, marking an increase of 121.91% compared to the previous close of $10.36. The 52 week high reached by this stock is $83.60 whilst the lowest price level in 52 weeks is $0.08.
Regencell Bioscience Holdings Ltd (RGC) has a 20-day trading average at $26.30 and the current price is -72.50% off the 52-week high compared with 28732.34% distance from its 52-week low. The 50-day simple moving average of the closing price is $15.85 and its 200-day simple moving average is $4.16. If we look at the stock’s price movements over the week, volatility stands at 53.32%, which decreases to 44.05% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 50.70 to suggest the stock is neutral.
The current price level is -12.58%, 45.04%, and 452.63% away from its SMA20, SMA50, and SMA200 respectively, with the RGC price moving below the 50-day SMA on current market day. Regencell Bioscience Holdings Ltd (RGC) stock is up 13.87% over the week and 43.43% over the past month. Its price is 25428.02% year-to-date and 17584.62% over the past year.
The company has a return on investment of -60.89% and return on equity of -48.45%. The beta has a value of 2.32. Price to book ratio is 44.55.
